Adding blinatumomab to chemotherapy reduces recurrence risk in standard-risk paediatric B-ALL

Nat Rev Clin Oncol. 2024 Dec 17. doi: 10.1038/s41571-024-00980-1. Online ahead of print.

NO ABSTRACT

PMID:39690161 | DOI:10.1038/s41571-024-00980-1